| KAI Pharmaceuticals Announces Phase 1 Results of KAI-4169 for the Treatment of ... - Business Wire (press release) |
|
|
Business Wire (press release)KAI plans to begin recruitment in a Phase 1b study in patients with ESRD and SHPT this quarter. “We are pleased to have successfully demonstrated safety and ... read more |